文献速递皮肤肿瘤

荷兰人群队列:首发黑色素瘤、鳞癌或基底细胞癌后不同皮肤肿瘤组合的风险(1989-2009)

Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-10-17

基于荷兰国家癌症登记(NCR)和埃因霍温地区癌症登记(ECR)1989-2009年数据,随访首发黑色素瘤、皮肤鳞状细胞癌(SCC)和基底细胞癌(BCC)患者至发生不同类后续皮肤肿瘤、死亡或研究结束。结果显示不同肿瘤组合的21年累积风险较高,标准化发病比和绝对超额风险在首诊后长达21年仍升高,提示共同致癌机制,可为随访指南和患者教育提供依据。

要点

  • 首发SCC或BCC后21年后续黑色素瘤累积风险男性1.7%/1.3%,女性1.3%/1.2%。
  • 首发黑色素瘤或BCC后21年后续SCC累积风险男性4.6%/9.3%,女性2.6%/4.1%。
  • 首发黑色素瘤或SCC后21年后续BCC累积风险男性13.2%/27.8%,女性14.9%/21.1%。

核心结论

  • 首发黑色素瘤、SCC或BCC后发生不同类后续皮肤肿瘤的累积风险较高,主要为角质形成细胞癌(KC)。
  • 所有肿瘤组合的相对风险和绝对风险均显著升高,且可持续至首诊后21年。

研究设计与样本

  • 基于荷兰国家癌症登记(NCR)1989-2009年全部黑色素瘤和SCC患者,以及埃因霍温地区癌症登记(ECR)同期全部BCC患者的 population-based 队列研究。
  • NCR纳入50 510例黑色素瘤患者和64 054例皮肤SCC患者;ECR纳入5 776例黑色素瘤、5 749例SCC和41 485例BCC患者。
  • 随访至发生不同类后续皮肤肿瘤(黑色素瘤、SCC或BCC)、死亡或研究结束,计算累积风险、标准化发病比(SIR)和绝对超额风险(AER)。

主要发现

  • 首发SCC或BCC后21年后续黑色素瘤累积风险:男性1.7%和1.3%,女性1.3%和1.2%。
  • 首发黑色素瘤或BCC后21年后续SCC累积风险:男性4.6%和9.3%,女性2.6%和4.1%。
  • 首发黑色素瘤或SCC后21年后续BCC累积风险:男性13.2%和27.8%,女性14.9%和21.1%。
  • SIR和AER在首诊黑色素瘤、SCC或BCC后长达21年仍保持升高。

临床怎么用

  • 上述累积风险、SIR和AER数据可用于制定随访指南和患者教育,以促进后续皮肤肿瘤的早期发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Skin cancer patients are primarily at increased risk of developing subsequent skin cancers of the same type. Shared risk factors might also increase the occurrence of a different type of subsequent skin cancer. OBJECTIVE: To investigate risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). METHODS: All melanoma and SCC patients included in the national Netherlands Cancer Registry (NCR) and all BCC patients included in the regional Eindhoven Cancer Registry (ECR) between 1989 and 2009 were followed until diagnosis of a subsequent different skin cancer (melanoma, SCC or BCC), date of death or end of study. Cumulative risks, standardized incidence ratios (SIR) and absolute excess risks (AER) of subsequent skin cancers were calculated. RESULTS: A total of 50 510 melanoma patients and 64 054 patients with a SCC of the skin were included (national data NCR). The regional data of the ECR consisted of 5776 melanoma patients, 5749 SCC patients and 41 485 BCC patients. The 21-year cumulative risk for a subsequent melanoma after a first SCC or BCC was respectively 1.7% and 1.3% for males and 1.3% and 1.2% for females; SCC after melanoma or BCC was 4.6% and 9.3% (males) and 2.6% and 4.1% (females); BCC after melanoma or SCC was respectively 13.2% and 27.8% (males) and 14.9% and 21.1% (females). SIRs and AERs remained elevated up to 21 years after the first melanoma, SCC or BCC. CONCLUSION: This large population-based study investigating risks of developing a different subsequent cutaneous malignancy showed high-cumulative risks of mainly KC and markedly increased relative and absolute risks of all tumour combinations. These estimates confirm a common carcinogenesis and can serve as a base for follow-up guidelines and patient education aiming for an early detection of the subsequent cancers.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. van der Leest RJT, Hollestein LM, Liu L, et al. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. J Eur Acad Dermatol Venereol. 2017. PMID: 28898461. doi:10.1111/jdv.14587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。